Mashup Score:15
U.S. Food and Drug AdministrationFDA grants accelerated approval to tucatinib with trastuzumab for colo - 1 week
Mashup Score:15
# coloncancer
Mashup Score:7
MD Anderson Cancer Center5 facts about colon cancer surgery - 3 days
Mashup Score:7
Many patients diagnosed with colon cancer require surgery as part of their treatment. Yi-Qian Nancy You, M.D., answers common questions about colon cancer surgery...
-
Colon cancer is typically treated with one of two types of surgery. Dr. Yi-Qian Nancy You breaks down the types of surgery, plus what patients can expect during recovery: https://t.co/0ehZjFKTby @NancyYouMD #ColonCancer #EndCancer - view on twitter
Mashup Score:1
lww.comWolters Kluwer Health - 1 week
Mashup Score:1
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers:...
-
Researcher spotlight: Dr. Babar Bashir is helping to make important inroads into the development of a #vaccine for patients with #coloncancer. The objective is to keep patients who have undergone frontline treatment from experiencing recurrence: https://t.co/mVS5FXF7on https://t.co/mVS5FXF7on - view on twitter
Mashup Score:1
NatureColonoscopies save lives. Why did a trial suggest they might not? - 1 week
Mashup Score:1
A major clinical study raised questions about one of the most celebrated cancer-screening procedures available, but a close look at the data tells a...
-
We see what we want to see. The study offers "layers of interpretation that cast colonoscopies in a more favourable light," -- Emily Sohn (@tidepoolsinc), @Nature https://t.co/WmRZoUdDHT #coloncancer #screening - view on twitter
Mashup Score:1
oncbrothers.comGI ASCO 2023 Highlights with Dr. Mark Lewis – ONC Brothers - 1 day
Mashup Score:1
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to...
-
Practice changing/informing studies from @ASCO #GI23 for community oncologists w/@marklewismd: - #SPOTLIGHT - #NAPOLI3 - 5FU bolus - #SUNLIGHT Full Interview: - https://t.co/FCEVbIJ8DM - Also on “Oncology Brothers” podcast @OncoAlert #OncEd #MedTwitter #gism #coloncancer https://t.co/FCEVbIJ8DM - view on twitter
A recent study has found evidence linking exposure to salmonella to an increased risk of colon cancer. Salmonella is a common bacterial disease...
-
Exposure to #Salmonella Linked With Colon Cancer https://t.co/XqS99FFKkH via @mydocwire #ColonCancer - view on twitter
PURPOSE Neoadjuvant chemotherapy (NAC) has potential advantages over standard postoperative chemotherapy for locally advanced colon cancer but requires formal evaluation. METHODS Patients with radiologically...
-
Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https://t.co/lutohxTwy2 #GI23 #ColonCancer @ASCO @JCO_ASCO https://t.co/lutohxTwy2 - view on twitter
Intercellular communication plays a critical role in the ever-evolving landscape of invasive cancers. Recent studies have elucidated the potential role of tunneling nanotubes (TNTs)...
-
#TunnelingNanotubes create intercellular communication networks that help drive invasive potential and evolution of drug resistance including in #pancreaticcancer & #coloncancer. This includes cell-to-cell transfer of RAS https://t.co/6a58TfJeSs https://t.co/6a58TfJeSs #GI23 https://t.co/6a58TfJeSs https://t.co/6a58TfJeSs - view on twitter
In the observational GALAXY arm of the CIRCULATE-Japan study, among 1,049 patients with stage II–IV colorectal cancer, those with presence of circulating tumor DNA...
-
RT @ArndtVogel: 🔥MRD & efficacy of adjuvant CTx in #coloncancer @NatureMedicine https://t.co/LjQdARm0NX ✅GALAXY 🇯🇵study 1039 pts 👉ctDNA+->… - view on twitter
More coverage:
#coloncancer
Consider it now ‘an option’ for locally advanced disease, editorialists...
-
Six weeks of neoadjuvant #chemotherapy for patients with operable #coloncancer is safe and results in downstaging, increased complete resection rates, and better disease control at 2 years, reported @lauramagill13, PhD. https://t.co/tfRNsSllt0 - view on twitter
On January 19, 2023, the Food and Drug Administration (FDA) granted accelerated approval to tucatinib (Tukysa, Seagen Inc.) in combination with trastuzumab for RAS...
It's great to see a drug initially developed for use against HER2+ breast cancer be extended for use in HER2+ colorectal cancer. A new option for some patients with stage 4 colon cancer, @FDAOncology https://t.co/ijDabkB6wj #crcsm #onctwitter #biomarkers #coloncancer #tucatinib - view on twitter